Table 2.
Effects of meloxicam therapy on starter ration intake (kg/d), water intake (L/d), and BW gain (kg/wk)
Item | Meloxicam treatment mean (LCL,1 UCL2) |
Placebo treatment mean (LCL, UCL) |
P-value |
---|---|---|---|
Starter intake,3 kg/d | |||
Week4 | |||
1 | 0.11 (0.09, 0.13) | 0.10 (0.09, 0.12) | 0.70 |
2 | 0.31 (0.23, 0.39) | 0.23 (0.15, 0.32) | 0.17 |
3 | 0.64 (0.46, 0.82) | 0.59 (0.41, 0.78) | 0.70 |
4 | 1.85 (1.61, 2.09) | 1.68 (1.42, 1.93) | 0.31 |
5 | 2.42 (2.24, 2.60) | 1.86 (1.62, 2.09) | <0.001 |
Overall | 1.12 (1.08, 1.16) | 0.97 (0.90, 1.04) | <0.001 |
Water intake,5 L/d | |||
Week6 | |||
1 | 1.7 (1.4, 2.2) | 1.4 (1.1, 1.8) | 0.25 |
2 | 2.8 (2.3, 3.5) | 2.6 (2.0, 3.2) | 0.52 |
3 | 4.0 (3.4, 4.6) | 3.1 (2.6, 3.7) | 0.03 |
4 | 4.6 (4.0, 5.1) | 2.7 (2.2, 3.1) | <0.001 |
5 | 5.7 (5.0, 6.5) | 3.7 (3.1, 4.3) | <0.001 |
6 | 8.0 (7.0, 9.0) | 5.8 (5.0, 6.6) | <0.001 |
Overall | 4.7 (4.3, 5.1) | 3.6 (3.2, 4.1) | <0.001 |
BW gain,7 kg/wk | |||
Week6 | |||
1 | 1.8 (0.9, 2.8) | 1.8 (0.8, 2.7) | 0.90 |
2 | 1.7 (0.8, 2.6) | 0.9 (−0.1, 1.8) | 0.17 |
3 | 3.7 (2.8, 4.6) | 3.4 (2.5, 4.3) | 0.65 |
4 | 5.1 (4.2, 6.0) | 3.8 (2.9, 4.8) | 0.06 |
5 | 5.8 (5.0, 6.7) | 5.1 (4.2, 6.0) | 0.21 |
6 | 7.3 (6.2, 8.4) | 5.8 (4.7, 6.9) | 0.06 |
Overall | 4.2 (4.0, 4.5) | 3.7 (3.4, 4.0) | <0.01 |
1LCL = lower 95% confidence limit.
2UCL = upper 95% confidence limit.
3Starter intake is adjusted for the effects of farm of origin.
4Starter intake is stratified by week, and time is measured relative to satisfying the starter consumption criteria. The criteria for time to starter consumption indicated that calves had to consume a minimum of 100 g of starter ration for 2 consecutive days.
5Water intake is adjusted for the effects of farm of origin, arrival BW, ambient maximum temperature, and ambient maximum relative humidity. The back-transformed mean, LCL, and UCL are presented.
6Water intake and BW gain are stratified by week, and time is measured relative to onset of diarrhea.
7BW gain is adjusted for the effects of farm of origin and age at treatment.